The one-day workshop will prelude the Parenteral Packaging Conference. An interactive afternoon session will ensure key learnings and substantial take-aways for all attendees.
Complex and sensitive drug products e.g. Monoclonal Antibodies, Oligonucleotides that have the potential to improve or advance existing treatments for patients around the world who rely on them for their health and well-being. To be successful, these companies depend on a continuous flow of new technologies for primary packaging systems, processes, and drug product manufacturing. Innovative solutions must be developed, tested and verified in order to fulfill global regulatory requirements. This means suppliers and pharma companies must work in harmony to implement these new technologies and support drug development and manufacturing.
The goal of this meeting is to examine and discuss in detail the many challenges that must be overcome for drugs administered in pre-filled syringes with a sharp focus on:
- New technologies that have the potential to improve drug products shelf-life: Including silicone free/low silicone solutions, particle reduction, etc.
- News technologies that support flexibility in drug product manufacturing: Including modularity in fill & finish, automated inspection and packaging solutions
- Moving from Vials to PFS – With attention to the many hurdles the industry must overcome in phase 3 studies when moving from vials to PFS for vaccines
- Traceability – An in-depth analysis of this new technology using case studies that shed light on how traceability is helping to ensure the integrity of the product and safety of the patient, reducing manufacturing costs and contributing to regulatory compliance.
